L-Thyroxin Inject Henning

Levothyroxine sodium, the active ingredient in L-Thyroxin Inject Henning, is a thyroid hormone presented as an injectable solution for intravenous use. It replaces deficient thyroid hormone in patients with hypothyroidism and provides rapid hormone replacement in myxedema coma, and helps normalize metabolic processes. The formulation is sterile and designed for hospital administration under professional supervision.

GNH USA supplies L-Thyroxin Inject Henning as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics, and pharmacies worldwide, ensuring reliable delivery across global markets with quality assurance.

Levothyroxine sodium is used as thyroid hormone replacement therapy to correct hormone deficiency in several clinical conditions.

- Hypothyroidism: restores normal thyroid hormone levels, improving metabolism and alleviating symptoms such as fatigue and weight gain. - Myxedema coma: provides rapid intravenous hormone replacement to reverse life‑threatening metabolic collapse. - Thyroid hormone replacement therapy: maintains euthyroid state in patients after thyroidectomy or radioactive iodine treatment.

Levothyroxine sodium may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache - Nausea or vomiting - Transient fever or chills - Mild tachycardia

Serious or Rare Side Effects: - Anaphylaxis - Angioedema - Severe arrhythmias (e.g., atrial fibrillation) - Myocardial infarction

When using L-Thyroxin Inject Henning, consider the following precautions.

- Dose adjustment: Reduce dose in elderly patients or those with cardiovascular disease. - Cardiac monitoring: Observe for tachyarrhythmias during initiation, especially in patients with coronary artery disease. - Adrenal insufficiency: Do not initiate therapy in untreated adrenal insufficiency; supplement glucocorticoids first. - Thyroid function testing: Verify TSH and free T4 levels before and after treatment to avoid over‑replacement. - Contraindication: Avoid use in acute myocardial infarction until stabilized. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levothyroxine sodium can interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Antithyroid drugs (e.g., methimazole, propylthiouracil): antagonize levothyroxine effect. - Estrogen therapy or oral contraceptives: increase levothyroxine requirement. - Amiodarone: alters thyroid hormone metabolism, may require dose adjustment.

Moderate Interactions (Monitor Closely): - Calcium or iron supplements administered intravenously: may reduce levothyroxine activity. - Beta‑blockers: may mask symptoms of excess thyroid hormone. - Warfarin: levothyroxine can affect INR, requiring closer monitoring.